approval · primary record
PEMETREXED DISODIUM
3 approval events · latest 2025-12-15
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-12-15 |
| Approval events | 3 |
| Brand | PEMETREXED DISODIUM |
| Sponsor | SANDOZ |
| Route | INTRAVENOUS |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-12-15 | FDA | NDA | PEMETREXED DISODIUM | SANDOZ | INTRAVENOUS |
| 2025-01-16 | FDA | NDA | PEMETREXED DISODIUM | ACCORD HLTHCARE | INTRAVENOUS |
| 2024-11-15 | FDA | NDA | PEMETREXED | SHILPA | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:30:03.217Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:pemetrexed-disodium
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Pemetrexed Disodium · compound